Advanced search
Publication Cover
Journal of Chemotherapy Volume 26, 2014 - Issue 1
Submit an article Journal homepage
259
Views
6
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404)

Hiroshi ImamuraDepartment of SurgeryToyonaka Municipal Hospital,Toyonaka, Osaka, JapanCorrespondence[email protected]
,
Tomono KishimotoDepartment of SurgerySakai Municipal Hospital, Sakai, Osaka, Japan
,
Hiroya TakiuchiCancer Chemotherapy CenterOsaka Medical College Hospital, Takatsuki, Osaka, Japan
,
Yutaka KimuraDepartment of SurgerySakai Municipal Hospital, Sakai, Osaka, Japan
,
Takashi MorimotoDepartment of SurgeryYao Municipal Hospital,Toyonaka, Osaka, Japan
,
Motohiro ImanoDepartment of SurgeryKinki University Hospital, Faculty of Medicine, Osaka-Sayama, Osaka, Japan
,
Shohei IijimaDepartment of SurgeryKinki Central Hospital, Itami, Hyogo, Japan
,
Keishi YamashitaKawagoe Gastroenterical HospitalKawagoe, Saitama, Japan
,
Kentaro MaruyamaDepartment of SurgeryMoriguchi Keijinkai Hospital, Moriguchi Osaka, Japan
,
Toshio OtsujiDepartment of Gastrointestinal Medicine`, Dongo Hospital, Yamatotakada, Nara, Japan
,
Yukinori KurokawaDepartment of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
&
Hiroshi FurukawaDepartment of SurgeryKinki University Hospital, Faculty of Medicine, Osaka-Sayama, Osaka, Japan
 show all
Pages 57-61 | Published online: 06 Dec 2013

References

  • Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
  • Vital Statistics Japan (Ministry of Health, Labour and Welfare). http://www.mhlw.go.jp/english/database/db-hw/index.html
  • Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, . S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215–21.
  • Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, . Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer. The Japan clinical oncology group study (JCOG9205). J Clin Oncol. 2003;21:54–9.
  • Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, . Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10(11):1063–9.
  • Narahara H, Iishi H, Imamura H, Tsuburaya A, Chin K, Imamoto H, . Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer. 2011;14(1):72–80.
  • Hamaguchi A .: Jin To Toseki [Kidney and Dialysis] 2002;52(3):273–7.
  • Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. Safety evaluation of oral Fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer:analysis of 3,758 patients. Cancer Chemother Pharmacol. 2008;61:335–343.
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
  • Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma (In Japanese), 13th edn. Tokyo:Kanehara;1999.
  • Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 2nd English edition response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria. Gastric Cancer. 2001;4:1–8.
  • Kurihara M, Aiko T. The new Japanese classification of gastric carcinoma: revised explanation of ‘response assessment of chemotherapy and radiotherapy for gastric carcinoma’. Gastric Cancer. 2001;4:9–13.
  • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, . New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst. 1999;92(3):205–16.
  • Koizumi W, Akiya T, Sato A, Sakuyama T, Sasaki E, Tomidokoro T, . Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study. Cancer Chemother Pharmacol. 2010;65:1093–99.
  • Shiroyama T, Kijima T, Komuta K, Yamamoto S, Minami S, Ogata Y, . Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer. Cancer Chemother Pharmacol. 2012;70:783–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.